Clinical Images: Tumor necrosis factor inhibitor–associated demyelination in a case of neuro-Behçet disease - Poll - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Case Study: Demyelination Associated with Tumor Necrosis Factor Inhibitors in Neuro-Behçet Disease

  • By

  • Eloise Norman

  • Gabor Major

  • September 24, 2026

Share

Original Source(s)

Clinical Images: Tumor necrosis factor inhibitor–associated demyelination in a case of neuro-Behçet disease

  • by Eloise Norman, Gabor Major

  • September 24, 2026

Related Content

Annual dementia cases may double by 2050

A global analysis reveals differences in dementia incidence by sex and country income, with implications for future prevention and care.

Patients engage with epilepsy monitor in real time, improving seizure detection

  • October 13, 2026

Tracking Proteins in the Cell’s Powerhouse

A labeling and electroporation workflow brings high-resolution NMR into intact organelles

  • October 13, 2026

  • 3 min